Nevertheless, this is the first study to rigorously determine the prevalence and etiology of cancer-related anemia in India and strengthens the notion that increments in Hb level would improve the QoL of cancer patients with anemia. This evidence concerns the gene GSTM1 and anemia (phenotype).